Moreover, E2 binding to GPER-1 inhibited in vivo tumor growth and angiogenesis and reduced the expression levels of VEGF, NF-κB/p65, STAT3, and the endothelial marker CD34 in TNBC cell xenograft tumors [72]. Here, NFKB1 is linked to neoplasm.